MAR 7 8 2005
- — Kogooal
S10(K) SUMMARY
Common/ Usual Name: Laser Instrument Miber and Procedure Kit
Product Trade Name: Vari Lase Endovenous Jaser Procedure Kit
Classification Name: Laser Surgical Instrument for use in General and Plasac
Surgery and in Dermatology
21 CER 878-4810 (Product Code GEX)
Manufacturer: Vascular Solutions, Inc.
6464 Sycamore Court
Minneapolis, Minnesota 55369
Establishment Registration: 2134812
Contact: Linda Busklein
Sr. Regulatory Affairs Associate
(763) 656-4217 phone
(763) 656-4253 fax
Performance Standards: No performance standards have been developed under
section 514 for this device.
Device Description: ‘The VARI-LASE procedure kit contains a 600m fiber and
the following accessories used to gain endovascular access:
0.035” /stainless steel guide wire (lengths from 75 to
150 cm)
5}*r/25. 45, or 55 cm introducer sheath
19 Gauge/7cm Percutaneous Entry Needle or
Micropuncture kit
Intended Use: The VARI-LASE procedure kit is indicated for the
treatment of varicose veins and varicosities associated with
superficial reflux of the Greater Saphenous Vein.
Summary of Non-Clinical Testing: Testing has been conducted to verify the biocompatility and
performance of the fiber.
Predicate Devices: Vari-Lase Endovenous Laser Procedure Kit
Conclusions: The VARI-LASE Procedure Kit is substantially equivalent
to the identified predicate device based on a comparison of
the indications for use and the components supplied and
the technological characteristics of the supplied
components.

prentce,
i J DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
(ASS
“ne Food and Drug Administration
MAR 18 2005 9200 Corporate Boulevard
Rockville MD 20850
Ms. Linda Busklein
Senior Regulatory Affairs Associate
Vascular Solutions, Inc.
6464 Sycamore Court
Minneapolis, Minnesota 55369
Re: K050021
Trade/Device Name: Vascular Solutions Vari-Lase” Endovenous Laser Procedure Kit
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: [J
Product Code: GEX
Dated: January 4, 2005
Received: January 5, 2005
Dear Ms. Busklein:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination docs not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801): good manufacturing practice requirements as sel
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1 050.

Page 2 - Ms. Linda Busklein
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
‘ marketed predicate device results in a classification for your device and thus. permits your device
to proceed to the market.
: If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please

contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CER Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www .fda.gov/edrh/industry/support/index hum!

Sincergly yours,

v- Ae a i

Miriam C. Provost, Pha).

Acting Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure

Indications for Use Statement

510(k) Number: Ko Sopa\
Device Name: Vascular Solutions Vari-J.ase® Endovenous Laser Procedure Kit
Indications for Use:
The VARI-LASE procedure kit is indicated for the treatment of varicose veins and
varicosities associated with superficial reflux of the Greater Saphenous Vein.

Prescription Use xX AND/OR Over-The-Counter Use

(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IFNEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)
- srative Page 1 of |
. al Wet ew ed
. LK 035 0024

